Three is better than two: humoral response in allogeneic HSCT after the third BNT162b2 SARS-CoV-2 mRNA vaccine

Eur Rev Med Pharmacol Sci. 2023 Aug;27(15):6914-6916. doi: 10.26355/eurrev_202308_33262.
No abstract available

Publication types

  • Letter

MeSH terms

  • BNT162 Vaccine
  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • SARS-CoV-2
  • mRNA Vaccines

Substances

  • BNT162 Vaccine
  • COVID-19 Vaccines